<DOC>
	<DOCNO>NCT00703144</DOCNO>
	<brief_summary>The pharmacokinetics piperacillin/tazobactam evaluated twenty septic patient renal failure undergo continuous veno-venous hemodiafiltration .</brief_summary>
	<brief_title>Pharmacokinetics Piperacillin/Tazobactam Patients Treated Continuous Renal Replacement Therapy</brief_title>
	<detailed_description>The pharmacokinetics piperacillin/tazobactam evaluated twenty septic patient renal failure undergo continuous veno-venous hemodiafiltration . This prospective study . Continuous replacement therapy continuous effect drug elimination could compromise effective antibiotic treatment . Patients receive standard course pip/tazo 4g intravenously 8 hourly administrate immediately CVVHDF start . Blood sample collect 30mn , 2h , 4h , 6h , 8h , 16h , 24h first second day . We measure plasma piperacillin/tazobactam concentration compare MICs whole dosing interval .</detailed_description>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<criteria>18 year age old . Females childbearing potential must negative pregnancy test screening . Subjects whose life expectancy estimate 7 day . Anuric patient require continuous venovenous hemodiafiltration Septic patient , severe sepsis septic shock Written inform consent give either patient member family Subjects history true allergy adverse drug reaction Pathogens whose antibiotic susceptibility prove . Patients impaired hepatic function Contraindication anticoagulation heparin Residual renal function Participation clinical trial Interruption treatment piper/tazo hemodiafiltration study . Patients psychiatric disorder serious medical condition opinion investigator may lead complexity patient management .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>piperacillin/tazobactam .</keyword>
	<keyword>Septic patient</keyword>
	<keyword>oliguric renal failure</keyword>
	<keyword>continuous veno-venous hemodiafiltration .</keyword>
</DOC>